Literature DB >> 10754348

Cardiac involvement in Werdnig-Hoffmann's spinal muscular atrophy.

J Finsterer1, C Stöllberger.   

Abstract

Despite the increasing interest in cardiac involvement (CI) of neuromuscular disorders, only few data are available on CI in spinal muscular atrophy (SMA). We tried to determine the cardiac manifestations of SMA, their incidence rates and the necessity of cardiac therapy in patients with SMA and CI. Eight patients with SMA, aged 10-79 years, underwent clinical cardiologic examination, ECG, echocardiography and ambulatory ECG. The most frequent findings were angina pectoris, palpitations, exertional dyspnea, ST abnormalities, couplets, thickened myocardium and diastolic dysfunction. In conclusion, cardiac manifestations of SMA mainly comprise ECG abnormalities and thickened myocardium. CI in SMA frequently necessitates cardiac therapy. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  1999        PMID: 10754348     DOI: 10.1159/000006968

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  12 in total

1.  Spinal muscle atrophy type 1 (Werdnig-Hoffman disease) with complex cardiac malformation.

Authors:  Wael El-Matary; Sunanda Kotagiri; Duncan Cameron; Ian Peart
Journal:  Eur J Pediatr       Date:  2004-06       Impact factor: 3.183

2.  Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy.

Authors:  Monir Shababi; Javad Habibi; Lixin Ma; Jacqueline J Glascock; James R Sowers; Christian L Lorson
Journal:  J Mol Cell Cardiol       Date:  2012-01-17       Impact factor: 5.000

3.  A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse.

Authors:  Paul N Porensky; Chalermchai Mitrpant; Vicki L McGovern; Adam K Bevan; Kevin D Foust; Brain K Kaspar; Stephen D Wilton; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2011-12-20       Impact factor: 6.150

Review 4.  Antisense oligonucleotides for the treatment of spinal muscular atrophy.

Authors:  Paul N Porensky; Arthur H M Burghes
Journal:  Hum Gene Ther       Date:  2013-05       Impact factor: 5.695

Review 5.  Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?

Authors:  Chiara Simone; Agnese Ramirez; Monica Bucchia; Paola Rinchetti; Hardy Rideout; Dimitra Papadimitriou; Diane B Re; Stefania Corti
Journal:  Cell Mol Life Sci       Date:  2015-12-18       Impact factor: 9.261

6.  Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery.

Authors:  Adam K Bevan; Kirk R Hutchinson; Kevin D Foust; Lyndsey Braun; Vicki L McGovern; Leah Schmelzer; Jennifer G Ward; Jeffrey C Petruska; Pamela A Lucchesi; Arthur H M Burghes; Brian K Kaspar
Journal:  Hum Mol Genet       Date:  2010-07-16       Impact factor: 6.150

7.  Developmental and degenerative cardiac defects in the Taiwanese mouse model of severe spinal muscular atrophy.

Authors:  Gillian K Maxwell; Eva Szunyogova; Hannah K Shorrock; Thomas H Gillingwater; Simon H Parson
Journal:  J Anat       Date:  2018-02-22       Impact factor: 2.610

8.  Downregulation of Survivin contributes to cell-cycle arrest during postnatal cardiac development in a severe spinal muscular atrophy mouse model.

Authors:  Lei Sheng; Bo Wan; Pengchao Feng; Junjie Sun; Frank Rigo; C Frank Bennett; Martin Akerman; Adrian R Krainer; Yimin Hua
Journal:  Hum Mol Genet       Date:  2018-02-01       Impact factor: 6.150

Review 9.  Spinal muscular atrophy: Broad disease spectrum and sex-specific phenotypes.

Authors:  Natalia N Singh; Shaine Hoffman; Prabhakara P Reddi; Ravindra N Singh
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-05       Impact factor: 5.187

Review 10.  The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.

Authors:  James N Sleigh; Thomas H Gillingwater; Kevin Talbot
Journal:  Dis Model Mech       Date:  2011-07       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.